Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights Nov 10, 2022 08:00AM
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights Nov 10, 2022 08:00AM
Candel Therapeutics Announces Closing of Initial Public Offering, Including the Partial Exercise of Underwriters’ Option Aug 17, 2021 08:00AM
Candel Therapeutics (CADL) IPO Opens Flat Jul 27, 2021 11:22AM
Candel Therapeutics (CADL) Prices 9M Share IPO at $8/sh Jul 27, 2021 05:19AM


Jul 26, 2021 09:05PM Candel Therapeutics Announces Pricing of Initial Public Offering